The use of oral ribavirin in the management of La Crosse viral infections

Medical Hypotheses

Volumn 72, Issue 2, 2009, Pages 190-192

  Haddow, Andrew D ^a   Haddow, Alastair D ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Skaggs Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG APPROVAL; DRUG EFFICACY; DRUG INHIBITION; FOOD AND DRUG ADMINISTRATION; HEPATITIS C; HUMAN; LA CROSSE VIRUS; PRIORITY JOURNAL; PROGNOSIS; VIRUS INFECTION;

ADMINISTRATION, ORAL; ENCEPHALITIS, CALIFORNIA; HUMANS; LA CROSSE VIRUS; RIBAVIRIN;

LA CROSSE VIRUS;

EID: 57749181291     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.05.043     Document Type: Article

References (32)

1. Thompson W.H., Kalfayan B., and Anslow R.O. Isolation of California Encephalitis Group Virus from a fatal human illness. Am J Epidemiol 81 (1965) 245-253
2. Calisher C.H. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 7 (1994) 89-116
3. Grimstad P. California serogroup viruses (1988), CRC Press, Inc., Boca Raton, Florida
4. Jones T.F., Craig A.S., Nasci R.S., Patterson L.E., Erwin P.C., Gerhardt R.R., et al. Newly recognized focus of La Crosse encephalitis in Tennessee. Clin Infect Dis 28 (1999) 93-97
5. Thompson W.H., and Beaty B.J. Venereal transmission of La Crosse (California encephalitis) arbovirus in Aedes triseriatus mosquitoes. Science 196 (1977) 530-531
6. Watts D.M., Pantuwatana S., DeFoliart G.R., Yuill T.M., and Thompson W.H. Transovarial transmission of LaCrosse virus (California encephalitis group) in the mosquito, Aedes triseriatus. Science 182 (1973) 1140-1141
7. Ksiazek T.G., and Yuill T.M. Viremia and antibody response to La Crosse virus in sentinel gray squirrels (Sciuris carolinensis and chipmunks Tamias striatus). Am J Trop Med Hyg 26 (1977) 815-821
8. Moulton D.W., and Thompson W.H. California group virus infections in small, forest-dwelling mammals of Wisconsin. Some ecological considerations. Am J Trop Med Hyg 20 (1971) 474-482
9. Pantuwatana S., Thompson W.H., Watts D.M., and Hanson R.P. Experimental infection of chipmunks and squirrels with La Crosse and Trivittatus viruses and biological transmission of La Crosse virus by Aedes triseriatus. Am J Trop Med Hyg 21 (1972) 476-481
10. Watts D.M., Morris C.D., Wright R.E., DeFoliart G.R., and Hanson R.P. Transmission of Lacrosse virus (California encephalitis group) by the mosquito Aedes triseriatus. J Med Entomol 9 (1972) 125-127
11. McJunkin J.E., de los Reyes E.C., Irazuzta J.E., Caceres M.J., Khan R.R., Minnich L.L., et al. La Crosse encephalitis in children. N Engl J Med 344 (2001) 801-807
12. Chun R.W., Thompson W.H., Grabow J.D., and Matthews C.G. California arbovirus encephalitis in children. Neurology 18 (1968) 369-375
13. Hilty M.D., Haynes R.E., Azimi P.H., and Cramblett H.G. California encephalitis in children. Am J Dis Child 124 (1972) 530-533
14. Balfour Jr. H.H., Siem R.A., Bauer H., and Quie P.G. California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics 52 (1973) 680-691
15. Rust R.S., Thompson W.H., Matthews C.G., Beaty B.J., and Chun R.W. La Crosse and other forms of California encephalitis. J Child Neurol 14 (1999) 1-14
16. McJunkin J.E., Khan R.R., and Tsai T.F. California - La Crosse encephalitis. Infect Dis Clin North Am 12 (1998) 83-93
17. Balkhy H.H., and Schreiber J.R. Severe La Crosse encephalitis with significant neurologic sequelae. Pediatr Infect Dis J 19 (2000) 77-80
18. Utz J.T., Apperson C.S., MacCormack J.N., Salyers M., Dietz E.J., and McPherson J.T. Economic and social impacts of La Crosse encephalitis in western North Carolina. Am J Trop Med Hyg 69 (2003) 509-518
19. Grabow J.D., Matthews C.G., Chun R.W., and Thompson W.H. The electroencephalogram and clinical sequelae of California arbovirus encephalitis. Neurology 19 (1969) 394-404
20. Cramblett H.G., Stegmiller H., and Spencer C. California encephalitis virus infections in children. Clinical and laboratory studies. JAMA 198 (1966) 108-112
21. de Los Reyes E.C., McJunkin J.E., Glauser T.A., Tomsho M., and O'Neal J. Periodic lateralized epileptiform discharges in La Crosse encephalitis a worrisome subgroup: clinical presentation electroencephalogram (eeg) patterns and long-term neurologic outcome. J Child Neurol 2 (2007) 21
22. Leyssen P., De Clercq E., and Neyts J. Molecular strategies to inhibit the replication of RNA viruses. Antiviral Res 78 (2008) 9-25
23. McJunkin J.E., Khan R., de los Reyes E.C., Parsons D.L., Minnich L.L., Ashley R.G., et al. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics 99 (1997) 261-267
24. McCormick J.B., King I.J., Webb P.A., Scribner C.L., Craven R.B., Johnson K.M., et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 314 (1986) 20-26
25. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res 78 (2008) 125-131
26. Jonsson C.B., Hooper J., and Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res 78 (2008) 162-169
27. Cassidy L.F., and Patterson J.L. Mechanism of La Crosse virus inhibition by ribavirin. Antimicrob Agents Chemother 33 (1989) 2009-2011
28. Ogle J.W., Toltzis P., Parker W.D., Alvarez N., McIntosh K., Levin M.J., et al. Oral ribavirin therapy for subacute sclerosing panencephalitis. J Infect Dis 159 (1989) 748-750
29. Crumpacker C., Bubley G., Lucey D., Hussey S., and Connor J. Ribavirin enters cerebrospinal fluid. Lancet 2 (1986) 45-46
30. Connor E., Morrison S., Lane J., Oleske J., Sonke R., and Connor J. Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection. Antimicrob Agents Chemother 37 (1993) 532-539
31. Jara P., Hierro L., de la Vega A., Diaz C., Camarena C., Frauca E., et al. Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection. Pediatr Infect Dis J 27 (2008) 142-148
32. Vandenbroucke J.P. When are observational studies as credible as randomised trials?. Lancet 363 (2004) 1728-1731